Nevro Corp (NYSE:NVRO)
$ 5.08 -0.26 (-4.87%) Market Cap: 189.40 Mil Enterprise Value: 157.99 Mil PE Ratio: 0 PB Ratio: 0.69 GF Score: 44/100

Nevro Corp Investor Briefing at North American Neuromodulation Society Transcript

Jan 25, 2020 / 11:00PM GMT
Juliet Cunningham;D. Keith Grossman
Nevro Corp. - VP of IR;Nevro Corp. - Chairman of the Board, CEO &

All right. Good afternoon, everybody. You guys get gold stars for being the die hards and staying around for a Saturday afternoon for seeing us. So thank you.

So I want to go over real quickly the agenda for today. So we're going to have a panel discussion, a couple of presentations. Keith is going to go over the company overview and most recent business developments; and Dr. David Caraway is joining us today to talk about PDN as well as some of our other NANS presentations. We'll follow all of that with a question-and-answer session. And we're going to try to stick to an hour here. I'd also like to welcome everyone on the webcast today. We appreciate you being on as well.

So of course, I have to say that we are going to make forward-looking statements, and those may or may not be material, and it's important to take a look at all of our normal SEC filings for a complete presentation of risk.

All right. I'd like to introduce Keith.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot